|
|
|
| Significance of Preservation of Spleen No.10 and No.11 Lymph Node Dissection in Gastric Cancer Surgery |
| WU Qi-ye, YI Guo-en, ZHANG Tian-zhu |
| The first people's Hospital of Xining City, Qinghai Province, Xining 810000 |
|
|
|
|
Abstract 【Objective】To explore the clinical effect and value of splenomegaly lymph node (No.10) and paraarterial lymph node (No.11) preserved in D2 radical gastrectomy. 【Methods】Sixty-six patients with advanced gastric cancer were divided into observation group (30 cases,lymph node dissection with spleen No.10 and No.11 preserved in D2 radical gastrectomy) and control group (36 cases, D2 radical gastrectomy combined with splenectomy for gastric cancer) according to the operation method.The operation time, bleeding volume, hospitalization time, number of lymph nodes, positive lymph node detection rate, operation complication rate and 1-year and 3-year survival rate were compared between the two groups. 【Results】The operation time of the observation group was longer than that of the control group, and the bleeding volume and hospitalization time of the operation were lower than those of the control group (P<0.05). There was no significant difference between the two groups in the number of lymph nodes cleaned and the detection rate of positive lymph nodes (P>0.05). The incidence of surgical complications in the observation group was 13.33% (4 / 30) lower than that in the control group (30.56% 11/ 36). The difference was statistically significant (χ2= 4.44, P<0.05). There was no significant difference between the observation group and the control group (P>0.05); there was no significant difference between the observation group and the control group (P>0.05). The median 3-year survival time was 32.0 months in the observation group and 29.0 months in the control group, there was no significant difference (P>0.05). 【Conclusion】Lymph node dissection with spleen No.10 and No.11 preserved in D2 radical gastrectomy have similar clinical effect and prognosis with splenectomy, and have lower complication rate and less trauma.
|
|
Received: 03 December 2018
|
|
|
|
|
|
[1] 王小虎, 朱代华, 段鹏飞,等. 进展期近端胃癌D2根治术中切脾与保脾的疗效对比[J].重庆医科大学学报, 2016,16(3):266-270.
[2] 何磊, 文刚, 涂从银,等. 保留脾脏的第10组与11组淋巴结整体清扫在胃癌D2根治术中的应用价值[J].中华消化外科杂志, 2016, 15(11):1113-1117.
[3] 黄庆兴, 曹爱红, 马俊,等. 以血管为导向的淋巴结清扫术在腹腔镜远端胃癌D2根治术中的应用价值[J].中华消化外科杂志, 2017,13(11):1132-1135.
[4] 余铭, 薛迪新, 施正超,等. 腹腔镜下胃癌D2淋巴结清扫的临床疗效及中期随访报告[J].中国内镜杂志, 2017, 23(11):68-73.
[5] 郑子芳, 吴黎敏, 简陈兴,等. 扶镜手在腹腔镜胃癌D2根治术中淋巴结清扫的配合体会[J].中国微创外科杂志, 2016, 16(9):860-862.
[6] 王俊江, 李晓武, 冯兴宇,等. 腹腔镜和开腹D2胃癌根治术淋巴结清扫效果分析[J].中华消化外科杂志, 2017, 16(11):1144-1148.
[7] 黄昌明, 陈起跃. 腹腔镜胃癌根治术保脾脾门淋巴结清扫出血预防与处理[J].中国实用外科杂志, 2017, 37(4):366-369.
[8] Viapiana P, Costa WL, Heber SDCR,et al.P-094Early and long-term outcomes of gastric cancer patients treated with perioperative chemotherapy and radical surgery in a single cancer center[J].Ann Oncol,2016, 27(2):28.
[9] 陈港心, 孙振强, 王海江. 中上部胃癌第10组淋巴结转移影响因素及预后意义[J].中华肿瘤防治杂志, 2016, 23(8):530-534.
|
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2019, 36(9): 1798-1800. |
|
|
|
|
2019, Vol. 36 
